Physician profile
Bill Dalosis
NPI 1497771604
$3,611.86
in general payments reported to CMS, 2019-2025
29 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $204 · 2021: $570 · 2022: $361 · 2023: $1,768 · 2024: $182 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,474 · Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,473.84 |
| Food and Beverage | $740.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,531.14 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $526.34 | 2020-2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $198.50 | 2020-2025 | Jublia |
| Sebela Pharmaceuticals INC. | $182.23 | 2019-2022 | |
| Smith+Nephew, INC. | $133.61 | 2019-2025 | Grafix |
| Organogenesis INC. | $96.80 | 2022-2025 | Puraply, Puraply Wound Matrix |
| Medtronic, INC. | $88.12 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $84.52 | 2025 | Krystexxa |
| Alfasigma USA, INC. | $78.34 | 2021 | |
| Kerecis Limited | $74.56 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osteomed LLC | $74.19 | 2019 | |
| Stryker Corporation | $66.15 | 2021-2025 | Flexband, Easyfuse, 7 X 23mm Citrelock Implant |
| Integra Lifesciences Corporation | $47.91 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tactile Systems Technology INC | $43.21 | 2025 | Flexitouch Plus, Nimbl |
| Bioventus LLC | $41.02 | 2022-2023 | Exogen Ultrasound Bone Healing System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $39.27 | 2021 | |
| Advanced Oxygen Therapy INC. | $35.51 | 2022 | |
| Orthofix Medical, INC. | $34.42 | 2023 | Physio-Stim, Spinal-Stim |
| Wright Medical Technology, INC. | $33.28 | 2019 | |
| Abbott Laboratories | $23.94 | 2020 | |
| Misonix INC | $22.82 | 2021 | |
| Reprise Biomedical, INC. | $22.36 | 2021 | |
| Boston Scientific Corporation | $21.85 | 2024 | |
| Novum Pharma, LLC | $21.37 | 2019 | |
| Melinta Therapeutics, LLC | $20.49 | 2019 | |
| Medartis INC. | $19.70 | 2019 | |
| Mimedx Group, INC. | $19.35 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $16.40 | 2023 | |
| Acell, INC. | $14.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bill Dalosis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.